Stock AB AB SCIENCE
Add to a list
To use this feature you must be a member
Log inSign up

All News AB Science

Equities

AB

FR0010557264

Market Closed - Euronext Paris
Other stock markets
 11:35:14 2024-05-29 am EDT 		5-day change 1st Jan Change
1.95 EUR -1.12% Intraday chart for AB Science -7.80% -45.15%
May. 30 Transcript : AB Science S.A. - Special Call
May. 29 AB Science: towards a negative opinion from the CHMP, listing suspended CF

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
AB Science is providing a summary of the live webcast held on May 30, 2024, giving an update on the application for conditional marketing authorization of masitinib in ALS
GL
Transcript : AB Science S.A. - Special Call
AB Science: towards a negative opinion from the CHMP, listing suspended
CF
AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS
GL
AB Science reports its revenues for the year 2023 and provides an update on its activities
GL
AB Science S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
AB Science: European patent granted for masitinib
CF
AB Science announces issuance of a European patent for masitinib in the treatment of severe mastocytosis with protection until 2036
GL
AB Science : A new publication in the medical journal Muscle & Nerve validates the use of the rate of decline of ALSFR-S score (ΔFS) for the design of clinical studies and the treatment choice for amyotrophic lateral sclerosis (ALS) patient
GL
AB Science: upbeat after legal success
CF
French Appeals Court Acquits AB Science CEO of Insider Trading Charges
MT
AB Science : The Paris Court of Appeal confirms the acquittal of the CEO of AB Science, Alain Moussy, and reduces the amount of the financial penalty imposed on AB Science
GL
AB Science announces a slight delay in the publication of its 2023 annual financial report
GL
AB Science announces a slight delay in the publication of its 2023 annual financial report
AQ
AB Science S.A. Announces Slight Delay in Publication of Annual Financial Report 2023
CI
AB Science's Reconsideration Request for ALS Treatment Granted Eligibility in Canada
MT
AB Science: reconsideration possible for masitinib in ALS
CF
AB Science announces that Health Canada has granted eligibility for reconsideration request for masitinib in ALS
GL
AB Science Announces Eligibility granted by Health Canada for Reconsideration Request for Masitinib in ALS
CI
AB Science: encouraging results for masitinib
CF
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AB Stock
  4. News AB Science